There is decreased risk for hospitalization in patients with heart failure who receive a high-dose inactivated influenza vaccine.

A novel color perimeter may serve as a potential tool to detect subtle visual changes dueto glucose dysfunction in preclinical diabetes.

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

Real-world data supports the use of nirmatrelvir-ritonavir in reducing the risk for severe COVID-19 outcomes among nonhospitalized patients.

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Since 2013, there has been an increase in the rate of physician attrition from clinical practice, according to a study.

In 2025, there was a greater than 50% rate of unfilled training positions in advanced heart failure and transplant cardiology.